These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 22244889)
1. CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion. Yanagi H; Wang L; Nishihara H; Kimura T; Tanino M; Yanagi T; Fukuda S; Tanaka S Biochem Biophys Res Commun; 2012 Feb; 418(1):104-9. PubMed ID: 22244889 [TBL] [Abstract][Full Text] [Related]
2. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro. Sato K; Ozawa S; Izukuri K; Kato Y; Hata R Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447 [TBL] [Abstract][Full Text] [Related]
3. Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice. Hemmeryckx B; van Wijk A; Reichert A; Kaartinen V; de Jong R; Pattengale PK; Gonzalez-Gomez I; Groffen J; Heisterkamp N Cancer Res; 2001 Feb; 61(4):1398-405. PubMed ID: 11245441 [TBL] [Abstract][Full Text] [Related]
4. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells. de Jong R; van Wijk A; Heisterkamp N; Groffen J Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945 [TBL] [Abstract][Full Text] [Related]
5. Involvement of the adapter protein CRKL in integrin-mediated adhesion. Uemura N; Salgia R; Ewaniuk DS; Little MT; Griffin JD Oncogene; 1999 Jun; 18(22):3343-53. PubMed ID: 10362355 [TBL] [Abstract][Full Text] [Related]
6. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl. Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N Biochem Biophys Res Commun; 2005 Aug; 333(4):1276-83. PubMed ID: 15982636 [TBL] [Abstract][Full Text] [Related]
7. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915 [TBL] [Abstract][Full Text] [Related]
8. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells. Arai A; Aoki M; Weihua Y; Jin A; Miura O Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119 [TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma. Scher RL Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613 [TBL] [Abstract][Full Text] [Related]
10. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma. Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071 [TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020 [TBL] [Abstract][Full Text] [Related]
12. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression. O-Charoenrat P; Rhys-Evans P; Eccles S Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283 [TBL] [Abstract][Full Text] [Related]
13. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Arai A; Nosaka Y; Kohsaka H; Miyasaka N; Miura O Blood; 1999 Jun; 93(11):3713-22. PubMed ID: 10339478 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of murine Crkl. de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571 [TBL] [Abstract][Full Text] [Related]
15. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor enhancement of HSC-1 human cutaneous squamous carcinoma cell adhesion and migration on type I collagen involves selective up-regulation of alpha 2 beta 1 integrin expression. Fujii K; Dousaka-Nakajima N; Imamura S Exp Cell Res; 1995 Jan; 216(1):261-72. PubMed ID: 7529189 [TBL] [Abstract][Full Text] [Related]
17. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38. Thomas SM; Zeng Q; Epperly MW; Gooding WE; Pastan I; Wang QC; Greenberger J; Grandis JR Clin Cancer Res; 2004 Oct; 10(20):7079-87. PubMed ID: 15501988 [TBL] [Abstract][Full Text] [Related]
18. Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Xue H; Atakilit A; Zhu W; Li X; Ramos DM; Pytela R Biochem Biophys Res Commun; 2001 Nov; 288(3):610-8. PubMed ID: 11676487 [TBL] [Abstract][Full Text] [Related]
19. BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl. Hemmeryckx B; Reichert A; Watanabe M; Kaartinen V; de Jong R; Pattengale PK; Groffen J; Heisterkamp N Oncogene; 2002 May; 21(20):3225-31. PubMed ID: 12082638 [TBL] [Abstract][Full Text] [Related]
20. The role of CT10 regulation of kinase-like in cancer. Guo C; Liu S; Sun MZ Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]